Skip to content
Clinical Trials – home

Cluster headache Basic Information

6 / 8 trials open to patients5 countries

In short

Cluster headache is a rare but extremely severe type of headache disorder that causes intense, one-sided pain around the eye. Often described as one of the most painful conditions someone can experience, it affects roughly 1 in every 1,000 people and tends to strike without warning, occurring in patterns or "clusters" that can last for weeks or months before disappearing, sometimes for years.

Key points

  • Cluster headache is one of the most painful conditions someone can experience, causing severe, one-sided pain around the eye that occurs in predictable patterns or "clusters."
  • Attacks can happen up to eight times per day during cluster periods, often at the same time each day or night, earning the nickname "alarm clock headaches."
  • Unlike migraine sufferers who prefer stillness, people with cluster headaches feel restless and need to pace or move during attacks.
  • Common pain relievers like ibuprofen and paracetamol don't work because cluster attacks reach peak intensity too quickly for these medications to take effect.
  • The condition is linked to the hypothalamus, explaining why attacks follow such predictable daily and seasonal patterns.
  • Smoking and alcohol are significant risk factors, with alcohol able to trigger attacks within hours during active cluster periods.
  • High-flow oxygen therapy and triptan medications are effective acute treatments that can stop or reduce the severity of individual attacks.
  • Cluster headaches tend to improve naturally with age, with people experiencing less frequent bouts and longer remission periods as they get older.

Epidemiology

Cluster headache is considered rare compared to other headache disorders. It affects an estimated 0.1 percent of the global population, which equals approximately 1 in every 1,000 people. Some studies suggest the prevalence may be as high as 1.3 percent in certain populations. This makes cluster headache far less common than migraine, which affects about 15 percent of people, or tension-type headache, which may affect up to 80 percent of individuals at some point in their lives.

The condition shows a clear gender pattern. Cluster headache is more common in men than women, with the male-to-female ratio approximately 2.5 to 1. However, the diagnosis rate among women has been increasing in recent years, suggesting that the condition may have been previously underrecognized in female patients.

While cluster headache can occur at any age, it most commonly begins when people are in their 20s through middle age, particularly in the 30s and 40s. The typical onset is around age 30. The condition may also affect children, though it is often misdiagnosed as migraine in younger patients.

Causes

The exact cause of cluster headache remains unknown, which makes understanding and treating this condition particularly challenging. Doctors and researchers have not yet identified a single definitive trigger that explains why some people develop cluster headaches while others do not.

Current research suggests that cluster headache may be related to the body's sudden release of certain chemicals. Specifically, scientists believe that histamine, a chemical released during allergic responses, or serotonin, a chemical made by nerve cells, may play a role in triggering attacks. These chemicals seem to be released in the area of the trigeminal nerve, which is responsible for sensation in the face.

A problem in a small area at the base of the brain called the hypothalamus may also be involved in causing cluster headaches. The hypothalamus is the part of the brain responsible for controlling many bodily functions including body temperature, thirst, sleep cycles, blood pressure, and heart rate. This connection helps explain why cluster headaches often follow such predictable patterns, occurring at the same time of day or the same season each year.

There appears to be a familial link for some individuals who develop cluster headaches. The condition tends to run in families, suggesting that genetics may play a role in who develops the disorder. If you have a close family member who experiences cluster headaches, your risk of developing the condition may be higher.

Cluster headache is not caused by another illness. It is a primary headache, meaning it is its own health condition rather than a symptom of another underlying medical problem. This distinguishes it from secondary headaches, which occur because of other health conditions such as ear infections, sinus problems, or dehydration.

Risk Factors

Several factors may increase the risk of developing cluster headaches or trigger individual attacks in people who already have the condition. Understanding these risk factors can help individuals manage their symptoms more effectively, though it does not guarantee prevention.

Smoking is strongly associated with cluster headaches. People who smoke or have smoked are more likely to develop this condition. Many individuals diagnosed with cluster headache have a history of cigarette use, making tobacco one of the most significant modifiable risk factors.

Alcohol consumption is a well-known trigger for cluster headache attacks, particularly during an active cluster period. Drinking alcohol when headaches are occurring can provoke an attack within a short time. During remission periods, alcohol may not have the same effect, but it remains important for people with cluster headaches to be cautious about drinking.

Certain environmental exposures and activities can also trigger attacks. Strong smells such as perfume, paint, nail varnish, or petroleum products may bring on a headache. Physical exertion or exercise has been identified as a potential trigger for some individuals. Bright light, including sunlight, and exposure to high altitudes during activities like trekking or air travel can also provoke attacks.

Heat exposure, whether from hot weather or hot baths, may trigger cluster headaches in susceptible individuals. Foods high in nitrites, such as bacon and preserved meats, have also been linked to triggering attacks. Certain medications and cocaine use are additional potential triggers.

Sleep patterns may also play a role. Many people with cluster headaches experience attacks at night, often waking up an hour or two after falling asleep. Some individuals with cluster headaches also have sleep apnea, though the connection between these two conditions is not fully understood.

Symptoms

Cluster headache attacks are characterized by extremely severe pain and a distinct set of accompanying symptoms. The pain typically starts suddenly, often without any warning, though some people may first experience slight discomfort or a burning feeling on one side of the head just before an attack begins.

The hallmark symptom is an extreme, sharp, burning, or stabbing pain that is almost always located on one side of the head only. This unilateral pain most commonly occurs in, behind, or around one eye. The pain may also spread to other areas of the face, head, and neck. Some people describe the sensation as boring or piercing. The intensity of cluster headache pain is often described as one of the most severe types of pain a person can experience, sometimes compared to the pain of passing a kidney stone or even childbirth.

When symptoms set in, it usually only takes five to 10 minutes for them to reach their worst intensity. Individual attacks last anywhere from 15 minutes to three hours, with most lasting between 30 minutes and two hours. The pain ends suddenly, and most people feel exhausted but pain-free after an attack.

During an attack, the affected individual experiences several other symptoms on the same side of the head as the pain. The eye on that side becomes red and watery, producing excessive tears. There may be swelling around the eye, and the eyelid may droop. The pupil in the affected eye may become smaller than the other. The nostril on the same side often becomes blocked or runny.

Facial flushing and sweating on the affected side are also common. Some people experience nausea during cluster headache attacks, and sensitivity to light may occur, though these symptoms are less common than in migraine.

A distinctive feature of cluster headaches is the restlessness they cause. Unlike people with migraines, who typically prefer to lie still in a dark, quiet room, those experiencing cluster headaches often feel agitated and unable to sit still. They may pace, rock back and forth, or need to move around constantly during the attack.

Cluster headaches occur in patterns. During a cluster period, which can last from several weeks to months, headaches happen multiple times per day. Some people may experience up to eight attacks in a single day, though one to three attacks daily is more typical. The attacks often occur at the same time each day, and many happen at night, earning them the nickname "alarm clock headaches." Nighttime headaches may feel more severe than those occurring during the day.

After a cluster period ends, the headaches stop completely. This pain-free time is called a remission period and can last for months or even years before another cluster begins. Most people have episodic cluster headaches, where cluster periods last from seven days to one year, separated by remission periods of at least three months. Up to 2 in 10 people with cluster headache have chronic cluster headache, where attacks persist for more than a year without remission, or remission lasts less than three months.

Some individuals experience cluster headaches seasonally, with attacks occurring during spring or autumn at the same time each year. The starting time and duration of cluster periods may be consistent from one bout to another, following a remarkably predictable pattern.

Prevention

While there is no cure for cluster headaches, several strategies may help reduce the frequency and severity of attacks. Prevention approaches focus on avoiding known triggers, maintaining healthy lifestyle habits, and using medications as recommended by healthcare providers.

Avoiding smoking is one of the most important preventive measures. If you smoke, quitting can potentially reduce your risk of developing cluster headaches or decrease the frequency of attacks if you already have the condition. Avoiding exposure to secondhand smoke is also advisable.

During cluster periods, it is crucial to avoid alcohol completely, as drinking can trigger attacks. Even small amounts of alcohol may provoke a headache within hours. Steering clear of other known triggers such as strong perfumes, paint fumes, and preserved meats high in nitrites can also help prevent attacks.

Maintaining a consistent sleep schedule may help regulate the body's circadian rhythms, which are the natural cycles that control sleep and wakefulness. Regularizing these rhythms has been shown to potentially reduce the incidence of cluster headache attacks. Going to bed and waking up at the same time each day, even on weekends, can support this goal.

Regular exercise offers multiple benefits that may indirectly help with cluster headaches. Daily physical activity has been linked to improved sleep quality, enhanced blood circulation to the brain, and reduced stress levels, all of which may contribute to fewer attacks. However, some people find that intense physical exertion can trigger attacks, so it is important to find a level of activity that works for you.

Practicing deep breathing exercises and yoga may provide relief for some individuals. Yoga combines effective breathing techniques with stretching and has been associated with reducing cluster headaches when practiced regularly, ideally about five sessions per week. Breathing exercises can also help relieve stress, which may be a contributing factor to attacks.

Doctors may prescribe preventive medications to help reduce the frequency and intensity of cluster headaches over time. These medications are different from those used to stop an attack once it has started. Preventive medications can include corticosteroids, which reduce inflammation and swelling, verapamil, which relaxes blood vessels, or lithium. The preventive regimen typically starts at the onset of a cluster period and continues until the person has been headache-free for at least two weeks, after which it may be slowly tapered.

Limiting caffeine intake by not drinking excessive amounts of coffee, tea, or soda may also be helpful. However, it is important not to quit caffeine suddenly, as this can trigger headaches in some people.

Pathophysiology

The pathophysiology of cluster headache refers to the changes in normal bodily functions that occur during an attack. Understanding these mechanisms helps explain why the symptoms are so distinctive and severe, even though much about cluster headache remains mysterious.

Cluster headache involves activation of the trigeminovascular complex, a system that connects the trigeminal nerve to blood vessels in the brain. The trigeminal nerve is the largest nerve in the face and is responsible for sensation in the face and head, particularly in the first division, which supplies the area around the eye and forehead. When this system is activated during a cluster headache, it leads to the severe, unilateral pain that characterizes the condition.

The prominent cranial autonomic symptoms that occur on the same side as the pain, such as tearing, eye redness, nasal congestion, and eyelid drooping, are explained by the activation of the trigeminal-autonomic reflex. This reflex involves connections between the trigeminal nerve and the autonomic nervous system, which controls involuntary body functions. When the trigeminal nerve is stimulated during a cluster attack, it triggers responses in the autonomic nervous system, leading to these characteristic symptoms.

The hypothalamus plays a crucial role in the unique timing patterns of cluster headaches. This small structure deep in the brain is involved in regulating circadian rhythms and seasonal cycles. The hypothalamus and the suprachiasmatic nucleus, which controls the body's internal clock, are thought to be responsible for the remarkable predictability of cluster attacks, including their tendency to occur at the same time of day and the same season each year. Neuroimaging studies have shown that the hypothalamus is activated during cluster headache attacks, supporting its central role in the condition.

The exact mechanisms by which the hypothalamus triggers cluster headache attacks remain unclear. Researchers believe that dysfunction in the hypothalamus may lead to the sudden release of chemicals such as histamine and serotonin in the area of the trigeminal nerve. These chemicals can cause blood vessels to dilate and may activate pain pathways, leading to the onset of an attack.

Cluster headache involves alterations in both the central nervous system, which includes the brain and spinal cord, and the peripheral nervous system, which connects the central nervous system to the rest of the body. The interaction between these systems creates the complex pattern of symptoms that define cluster headache attacks.

The condition tends to improve with age, with people experiencing less frequent cluster periods and longer remission times as they get older. This natural evolution suggests that changes in brain function over time may influence the course of the disorder, though the specific biological mechanisms behind this improvement are not yet fully understood.

Did you know?

  1. Cluster headaches are sometimes called "alarm clock headaches" because they often wake people up at exactly the same time each night, as if set by an internal alarm.
  2. The male-to-female ratio for cluster headache is about 2.5 to 1, but the diagnosis rate in women has been increasing, suggesting the condition may have been historically underrecognized in females.
  3. Some people with cluster headaches experience attacks seasonally, with headaches appearing during spring or autumn at the same time each year, demonstrating the condition's remarkable connection to the body's internal biological clock.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Cluster headache

Recruiting trials first

See all 8 trials →
Quick filters

8 clinical trials in this condition

Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:LYSERGIDE
  • Sponsor:Stichting Radboud universitair medisch centrum
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Norwegian University Of Science And Technolology
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Oxybate
  • Sponsor:Leids Universitair Medisch Centrum (LUMC)
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Candesartan
  • Sponsor:Helse Bergen HF
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Candesartan
  • Sponsor:Helse Bergen HF
See all 8 trials →filters applied: condition = Cluster headache

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).